🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Cardiogenic Shock

Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI NCT07149714NA1 site📍 Moscow National Medical Research Center for Cardiology, Ministry o… · Tests: iVAC 2L The Clinical and Hemodynamic Course of Cardiogenic Shocks Hospitalized in Critical Care NCT05752383n/a1 site📍 Amiens Centre Hospitalier Universitaire, Amiens China Extracorporeal Life Support Registry NCT04158479n/a1 site📍 Beijing Beijing Anzhen Hospital · Tests: ECMO A Study on the Effects of Left Ventricular Unloading in the Setting of VA ECMO Support NCT05913622NA14 sites📍 Bruges📍 Genk📍 Ghent Erasmus Medical Center · Tests: Intra-aortic balloon pump Early Beta Blocker Administration in STEMI Patients With SCAI B Status NCT06967194NA1 site📍 Tel Aviv Tel-Aviv Sourasky Medical Center · Tests: Metoprolol (MET), Plcacebo Inotropic Effects of Vasopressin Versus Noradrenaline In Patients With Vasoplegic Syndrome After Cardiac Surgery NCT06934798Phase 41 site📍 São Paulo University of Sao Paulo · Tests: Vasopressin intravenous infusion, Norepinephrine intravenous infusion Naples Federico II Intensive Cardiac Care Unit Registry (Naples FED2-ICCU Registry) NCT06162247n/a1 site📍 Naples Federico II University CRP Apheresis in Infarct-Related Cardiogenic Shock NCT07687017NA1 site📍 Leipzig Leipzig Heart Science gGmbH · Tests: Selective C-reactive protein apheresis (PentraSorb®-CRP), Standard of care Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE NCT07515508n/a4 sites📍 Bad Krozingen📍 Freiburg im Breisgau📍 Nuremberg University Heart Center Freiburg - Bad Krozingen Accelerated vs. Standard Continuous Renal Replacement Therapy for Patients With Cardiogenic Shock Undergoing Veno-arterial ExtraCorporeal Membrane Oxygenator NCT06696235Phase 42 sites📍 Seoul📍 Seoul Samsung Medical Center · Tests: Early initiation of continuous renal replacement therapy, Standard initiation of continuous renal replacement therapy Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure NCT07527156Phase 41 site📍 Prague Institute for Clinical and Experimental Medicine · Tests: Ketone Monoester (KE) The Current Status and Clinical OUTcomes of Cardiogenic Shock Patients And the Role of Specialist in Cardiovascular Critical Care Unit NCT05415332n/a1 site📍 Seoul Yonsei University CytOSorb TreatMent Of Critically Ill PatientS Registry NCT05146336n/a28 sites📍 Klagenfurt📍 Vienna📍 Aachen CytoSorbents, Inc · Tests: CytoSorb The ECMOCYP (cytochromes P450 Activity) Study NCT06662084n/a1 site📍 Geneva University Hospital, Geneva · Tests: phenotype CARDSUP - SWISS Circulatory Support Registry NCT04117230n/a5 sites📍 Basel📍 Bern📍 Lucerne Insel Gruppe AG, University Hospital Bern Digital Out-of-hospital Management on Clinical Outcomes in Patients With Early Cardiogenic Shock NCT07085221NA1 site📍 Wuhan Renmin Hospital of Wuhan University · Tests: hospital external management Assessment of ECMO in Acute Myocardial Infarction Cardiogenic Shock NCT04184635NA1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: VA-ECMO Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock NCT04020263Phase 328 sites📍 Strasbourg📍 Marseille📍 Caen Pr Bruno LEVY · Tests: Levosimendan 2.5 MG/ML Injectable Solution, Placebo ECMO LEft Ventricle UNloading Strategy NCT06766006n/a1 site📍 Maastricht Maastricht University Medical Center · Tests: Venoarterial extracorporeal life support (VA ECLS) implant Evaluation of the Efficacy of Early Implantation of a Percutaneous Left Ventricular Assist Devices in Acute Coronary Syndrome Complicated by Cardiogenic Shock Compared to Conventional Therapy: a Prospective, Multicenter, Randomized, Controlled and Open-label Clinical Trial NCT05366452NA1 site📍 Marseille Assistance Publique Hopitaux De Marseille · Tests: IMPELLA CP, Conventional therapy Pulmonary Artery Catheter in Cardiogenic Shock Trial NCT05485376NA1 site📍 Boston Tufts Medical Center · Tests: Pulmonary Artery Catheter Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock NCT05298124NA4 sites📍 Rochester📍 Ottawa📍 Toronto Ottawa Heart Institute Research Corporation · Tests: Transcatheter edge-to-edge repair, Medical therapy Impella Reverse Remodeling in End-Stage Heart Failure NCT06800716n/a1 site📍 New York Columbia University Clinical Evaluation of NIRSense Tissue Oximetry Sensor Monitoring to Early Detect Cardiogenic Shock NCT07825363n/a1 site📍 Weston NIRSense Inc. · Tests: NIRSense Tissue Oximetry Sensor System OPTIMIZE 5.5 - Optimizing Impella 5.5 Outcomes Through Advanced Data Science NCT07619144n/a1 site📍 Vienna Medical University of Vienna · Tests: Micro-axial flow pump support Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Due to HFrEF NCT06078436NA1 site📍 Seoul Min-Seok Kim · Tests: Pulmonary artery catheter Randomized Evaluation of Istaroxime for Stabilization in Acute Heart Failure-Cardiogenic Shock NCT07583446Phase 2, Phase 31 site📍 Yerevan Seismic Pharmaceuticals Operations LLC · Tests: istaroxime, placebo Cardiac Power Output in Cardiogenic Shock Patients NCT05700617EARLY Phase 11 site📍 Chicago University of Chicago · Tests: 1:1 Randomization to receive milrinone Polish Nationwide Registry of Diagnostics, Treatment and Outcome in Patients With Cardiogenic Shock NCT06697093n/a2 sites📍 Wroclaw📍 Wroclaw Wroclaw Medical University Prognosis of Patients With Mixed Cardiogenic-Vasoplegic Shock NCT07354568n/a1 site📍 Amiens Centre Hospitalier Universitaire, Amiens
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy